≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_MYELODYSP_SYNDR_EXALLC for full statistics.

Myelodysplastic syndrome

EFO Endpoint Browser

C3_MYELODYSP_SYNDR

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — D46
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9980|998[2-5]|9989
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

298

4. Check minimum number of events

None

298

5. Include endpoints

None

298

6. Filter based on genotype QC (FinnGen only)

298

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 298 106 192
Unadjusted period prevalence (%) 0.07 0.04 0.08
Median age at first event (years) 76.91 78.03 76.30

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
274
Matched controls
2741
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
193.4
162
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
569.3
193.0
171
8
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
47.4
117.8
146
64
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
442.2
115.6
108
*
XW000
NOMESCO Finland
Bone marrow biopsy
45.0
111.1
139
61
D64.9
ICD-10 Finland
Anaemia, unspecified
16.3
84.3
160
217
WW500
NOMESCO Finland
Blood transfusion
32.3
83.6
113
58
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
860.2
70.3
66
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
+∞
45.0
42
*
B03XA02
ATC
darbepoetin alfa; parenteral
29.7
43.7
59
25
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
253.6
43.2
43
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
+∞
39.5
37
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
113.1
36.8
39
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
29.5
36.4
49
20
A04AA01
ATC
ondansetron; systemic, rectal
12.4
31.6
59
59
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.6
29.6
37
11
L03AA02
ATC
filgrastim; parenteral
20.2
28.6
43
25
B03XA01
ATC
erythropoietin; parenteral
28.3
27.4
37
15
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
149.0
26.1
27
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
68.4
22.2
25
*
127
Kela drug reimbursment
Transplant complication
31.0
21.4
28
10
D70.89
ICD-10 Finland
Neutropenic splenomegaly
31.0
21.4
28
10
A05AA02
ATC
ursodeoxycholic acid; oral
37.3
19.2
24
7
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
19.0
18
*
L04AD01
ATC
ciclosporin; systemic
23.8
18.6
26
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
17.9
78
239
9982/3-C42.1
ICD-O-3
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia of bone marrow
+∞
16.8
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.8
16.7
32
33
ZX112
NOMESCO Finland
Subcutaneous
13.4
16.3
28
23
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.4
15.8
35
47
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
60.1
15.0
17
*
ZX120
NOMESCO Finland
Intravenous
4.5
14.1
52
134
WW200
NOMESCO Finland
Immunization
17.4
13.7
21
13
1BC07
NOMESCO Finland
NA
+∞
13.6
13
*
J02AC03
ATC
voriconazole; systemic
+∞
13.6
13
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
42.3
13.3
16
*
R50.9
ICD-10 Finland
Fever, unspecified
3.5
13.2
68
235
9985/3-C42.1
ICD-O-3
Myelodysplastic syndrome with multilineage dysplasia of bone marrow
+∞
12.6
12
*
9980/3-C42.1
ICD-O-3
Myelodysplastic syndrome with single lineage dysplasia of bone marrow
+∞
12.6
12
*
B82
ICPC
Anaemia other/unspecified
8.2
12.2
27
36
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
11.5
11
*
D46.4
ICD-10 Finland
Refractory anaemia, unspecified
+∞
11.5
11
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
11.5
11
*
Z51.5
ICD-10 Finland
Palliative care
4.2
11.5
45
122
SPAT1088
SPAT
Blood transfusion
26.3
11.3
15
6
L04AA06
ATC
mycophenolic acid; systemic
18.8
10.9
16
9
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.1
10.8
29
52
H02AB06
ATC
prednisolone; systemic
2.3
10.1
147
912
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
21.0
9.9
14
7
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.4
9.5
22
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
9.4
31
71
M04AA01
ATC
allopurinol; systemic
2.6
9.2
75
342
J01MA12
ATC
levofloxacin; systemic
2.5
8.8
76
359
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
92.7
8.5
9
*
B73
ICPC
Leukaemia
92.7
8.5
9
*
V03AC03
ATC
deferasirox; oral
92.7
8.5
9
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
8.4
32
85
D46
ICD-10 Finland
Myelodysplastic syndromes
+∞
8.4
8
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
8.3
27
61
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
8.2
98
540
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
8.1
120
729
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.8
8.1
11
5
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
8.0
28
69
J05AB11
ATC
valaciclovir; oral
3.1
7.9
45
165
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
7.5
53
221
B99
ICPC
Blood/lymph/spleen disease other
41.1
6.8
8
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
41.1
6.8
8
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.8
6.7
18
33
N02AA05
ATC
oxycodone; systemic
2.3
6.6
64
316
TGC00
NOMESCO Finland
Bronchial lavation
6.5
6.6
16
26
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
6.5
23
58
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
71.4
6.5
7
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
71.4
6.5
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
6.4
106
658
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
18.5
6.3
9
5
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
6.3
6
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
27.3
6.3
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.2
132
902
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
7.0
6.1
14
21

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
108
23
73.08
192.47
1.4
1.1
—
—
—
0
0
92
45
29.13
126.54
3.8
1.6
—
—
—
0
0
75
29
34.22
111.85
1.8
1.2
—
—
—
0
0
157
333
8.85
80.40
7.5
2.4
2.0
1.7
%
0.89
139
298
132
240
9.08
77.39
6.7
2.4
76.1
65.6
e9/l
0.38
108
200
57
39
17.84
65.68
10.8
3.6
1.6
0.7
%
1.65
44
33
93
134
9.64
65.56
2.4
1.7
1.0
1.6
g/l
8.05
78
119
96
181
7.35
52.52
13.5
3.7
2.0
0.7
%
2.01
67
66
38
25
17.28
44.18
10.3
2.9
44.7
56.2
%
0.87
19
17
37
34
12.28
35.35
15.2
4.2
—
—
—
0
0
78
174
5.72
34.86
13.8
3.7
0.2
0.1
%
0.24
58
62
74
158
5.90
34.67
14.3
3.5
1.3
0.4
%
1.65
41
46
83
216
4.94
30.76
2.7
2.3
65.8
65.4
g/l
0.16
76
192
159
667
3.97
30.75
25.2
5.1
—
—
—
0
0
31
27
12.70
30.52
1.2
1.1
—
—
—
0
0
75
183
5.14
29.97
2.5
2.1
—
—
—
0
0
21
10
22.52
27.90
1.2
1.6
—
—
—
0
0
31
5
68.85
27.53
2.9
3.4
—
—
—
0
0
30
30
11.01
26.93
1.3
1.2
—
—
—
0
0
26
21
13.47
26.69
1.3
1.1
294.6
363.3
u/ml
0.20
17
12
21
12
18.75
25.76
2.5
2.9
—
—
—
0
0
27
25
11.78
25.47
1.4
1.4
—
—
—
0
0
64
160
4.82
24.55
14.7
3.8
1.4
0.1
%
1.25
44
54
57
131
5.14
24.14
3.9
3.0
10.9
10.6
g/l
0.15
51
118
35
51
7.64
23.44
2.9
3.5
—
—
—
0
0
46
95
5.54
21.89
1.4
1.3
—
—
—
0
0
41
77
6.01
21.56
2.6
2.8
9.5
1.4
ratio
—
5
7
41
78
5.94
21.27
2.6
2.9
70.1
172.0
mg/l
0.59
36
59
40
78
5.77
20.20
2.6
2.9
100.1
35.6
mg/l
0.42
33
60
144
698
3.06
19.90
19.0
2.7
—
—
—
0
0
168
889
3.04
19.78
24.1
5.4
0.7
0.6
%
0.73
158
829
170
914
3.00
19.30
25.0
5.3
2.0
2.8
%
1.95
160
846
100
400
3.26
19.18
2.5
2.4
18.5
11.8
umol/l
6.42
94
363
170
920
2.97
18.96
26.8
5.6
11.1
9.0
%
2.53
160
858
171
934
2.95
18.66
26.2
5.6
32.2
25.0
%
6.22
160
858
122
561
2.99
18.20
5.6
2.9
348.6
8217.7
umol/l
2.96
115
456
89
350
3.20
17.36
2.5
2.4
37.3
21.5
%
6.09
73
303
57
168
3.96
17.33
1.4
1.6
—
—
—
0
0
53
150
4.08
17.03
1.5
1.5
—
—
—
0
0
165
916
2.80
16.94
22.0
5.3
48.7
59.7
%
11.84
153
850
51
141
4.16
16.91
1.5
1.5
—
—
—
0
0
110
506
2.86
16.06
17.3
2.5
—
—
—
0
0
44
114
4.36
15.85
1.9
2.0
7.9
3.6
ug/l
0.23
33
98
119
574
2.79
15.83
2.3
1.8
1232.7
1149.6
nmol/l
0.34
91
420
166
957
2.66
15.32
30.1
4.4
—
—
—
0
0
79
316
3.04
14.72
7.2
4.7
1.1
1.0
mmol/l
0.72
74
288
149
827
2.60
14.70
5.3
2.7
588.6
166.6
ug/l
8.87
133
733
169
1001
2.59
14.48
22.4
5.2
0.1
0.2
e9/l
7.16
146
885
22
34
6.91
13.84
5.0
1.7
33.0
32.7
pg
0.08
22
34
163
977
2.48
13.23
20.4
5.2
1.4
1.8
e9/l
3.54
146
869
81
349
2.81
13.04
6.6
2.9
0.8
0.8
mmol/l
0.66
74
323
124
667
2.47
12.62
2.8
2.2
3.3
3.2
mg/l
0.08
105
564
138
780
2.43
12.58
9.2
4.3
—
—
—
0
0
159
958
2.41
12.54
19.4
5.1
0.7
0.6
e9/l
0.15
142
834
53
183
3.31
12.53
1.9
1.3
—
—
—
0
0
159
964
2.39
12.29
19.4
5.1
0.0
0.0
e9/l
1.63
141
844
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
17
23
7.78
11.96
1.6
1.5
—
—
—
0
0
15
5
31.45
11.76
1.1
1.0
—
—
—
0
0
16
21
7.99
11.53
1.1
1.0
—
—
—
0
0
33
89
4.05
11.20
1.8
1.9
37.4
35.8
g/l
0.71
27
72
173
1144
2.22
10.21
38.3
8.2
3.8
4.4
e9/l
0.27
157
1013
11
11
10.34
9.60
5.8
1.4
—
—
—
0
0
9
0
+∞
9.42
1.0
0.0
—
—
—
0
0
24
59
4.34
9.17
1.3
1.4
—
—
—
0
0
78
386
2.38
9.13
17.6
4.9
—
—
—
0
0
71
338
2.44
9.04
1.8
2.0
—
—
—
0
0
13
18
7.51
8.91
9.3
1.8
0.7
0.9
e9/l
—
8
8
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
8
0
+∞
8.37
1.0
0.0
—
—
—
0
0
167
1160
2.00
7.86
18.0
5.5
15.2
12.1
umol/l
2.28
158
1084
13
21
6.43
7.78
1.2
1.0
—
—
—
0
0
73
381
2.21
7.40
3.1
1.9
30.6
29.8
s
0.29
68
366
153
1059
1.91
7.00
10.5
5.2
1.2
1.2
mmol/l
2.29
131
945
164
1168
1.90
6.81
12.1
6.0
1.2
1.2
mmol/l
1.53
131
964
59
311
2.12
5.74
1.3
1.4
2.3
2.9
g/l
0.95
46
183
17
46
3.86
5.73
1.2
1.2
—
—
—
0
0
24
578
0.36
5.68
3.0
3.2
0.9
0.9
ug/l
0.08
15
402
5
0
+∞
5.22
1.2
0.0
7.8
—
%
—
5
0
44
220
2.17
4.87
7.1
3.9
—
—
—
0
0
13
35
3.84
4.41
1.7
1.4
—
—
—
0
0
8
9
9.09
4.30
1.1
1.1
—
—
—
0
0
73
455
1.80
4.29
2.1
1.3
—
—
—
0
0
149
1851
0.61
4.25
4.0
5.4
2.0
2.5
mmol/l
7.78
122
1627
139
1037
1.64
4.20
9.8
4.1
32.2
34.1
g/l
2.33
123
954
134
996
1.63
4.08
2.9
2.2
89.1
90.8
pmol/l
0.16
85
533
144
1792
0.62
4.00
6.2
6.8
40.9
41.8
mmol/mol
0.36
126
1619
76
493
1.73
3.86
30.4
5.9
—
—
—
0
0
100
711
1.61
3.55
10.1
3.7
7.4
7.4
ph
1.33
17
145
8
13
6.29
3.52
1.6
1.3
—
—
—
0
0
27
518
0.47
3.49
2.4
3.3
—
—
—
0
0
18
70
2.67
3.45
3.6
3.9
—
—
—
0
0
10
27
3.80
3.38
1.9
1.4
—
—
—
0
0
145
1770
0.65
3.37
3.7
4.7
1.3
1.4
mmol/l
2.40
117
1557
147
1785
0.65
3.29
3.7
4.7
3.7
4.3
mmol/l
8.56
118
1592
37
204
1.93
3.17
1.4
1.3
460.0
547.9
titre
0.14
12
53
8
16
5.11
3.07
2.3
1.9
—
—
—
0
0
22
103
2.23
2.89
1.5
1.3
—
—
—
0
0
143
1718
0.68
2.79
4.0
4.2
1.2
1.2
mmol/l
0.30
118
1502
8
19
4.30
2.69
1.0
1.2
—
—
—
0
0
11
38
2.97
2.61
2.3
3.4
—
—
—
0
0
115
1428
0.68
2.59
5.3
4.5
—
—
—
0
0
7
16
4.45
2.49
1.0
1.0
—
—
—
0
0
10
36
2.84
2.22
15.1
2.4
56.6
60.9
%
—
10
36
5
9
5.63
2.22
1.0
1.9
—
—
—
0
0
7
19
3.75
2.16
3.6
2.3
—
—
—
0
0
64
456
1.51
2.16
1.9
1.7
2.4
1.5
mg/l
1.12
52
366
7
20
3.56
2.06
1.0
1.1
—
—
—
0
0
21
113
1.92
1.97
3.3
3.7
24.2
24.1
mmol/l
0.06
21
102
10
39
2.62
1.94
1.3
1.3
—
—
—
0
0
39
258
1.59
1.83
2.2
1.7
—
—
—
0
0
22
124
1.84
1.81
6.0
2.6
5.4
4.2
e9/l
0.32
14
82
33
212
1.63
1.74
2.1
2.1
0.2
0.2
g/l
0.61
28
192
79
993
0.72
1.70
4.5
5.5
2.2
3.8
ug/l
1.33
67
862
11
49
2.29
1.65
1.6
1.3
—
—
—
0
0
164
1847
0.75
1.65
5.2
5.1
6.2
6.2
mmol/l
0.03
130
1619
38
258
1.54
1.61
1.3
1.3
—
—
—
0
0
182
2016
0.75
1.60
28.3
10.8
24.3
23.6
u/l
0.23
169
1912
36
243
1.55
1.56
3.3
1.4
—
—
—
0
0
178
1974
0.76
1.55
46.5
18.2
—
—
—
0
0
10
44
2.32
1.55
1.3
1.5
—
—
—
0
0
8
33
2.46
1.55
3.1
2.6
—
—
—
0
0
20
116
1.78
1.53
5.5
7.5
—
—
—
0
0
86
688
1.35
1.52
2.5
2.3
48.4
57.8
u/l
2.15
75
636
48
645
0.70
1.51
2.7
3.1
1336.6
155.0
mg/l
0.45
34
446
80
636
1.35
1.47
2.0
1.7
19.6
20.1
nmol/l
0.11
72
530
21
128
1.69
1.37
5.8
3.9
—
—
—
0
0
6
23
2.64
1.37
1.8
2.7
—
—
—
0
0
53
686
0.72
1.33
3.8
3.8
16.2
10.7
mg/mmol
0.28
34
456
49
640
0.72
1.30
2.8
3.1
6.3
7.1
mmol/l
0.74
40
521
12
62
1.97
1.29
1.3
1.3
—
—
—
0
0
53
403
1.38
1.28
18.1
31.2
1.6
1.4
inr
—
8
48
45
593
0.72
1.26
5.1
4.4
—
—
—
0
0
123
1058
1.28
1.26
7.2
11.7
1.4
1.4
inr
0.05
27
311
7
141
0.48
1.24
1.3
1.4
—
—
—
0
0
10
49
2.08
1.23
1.2
1.5
—
—
—
0
0
156
1734
0.79
1.22
4.8
4.6
2.2
2.1
mu/l
0.37
128
1494
5
19
2.66
1.22
1.8
1.4
54.4
70.8
%
—
5
12
5
19
2.66
1.22
3.4
4.0
—
—
—
0
0
34
243
1.45
1.16
3.3
3.6
1.2
1.8
mmol/l
0.28
28
188
29
201
1.49
1.15
4.6
3.7
—
—
—
0
0
193
2085
0.79
1.14
82.5
27.1
100.3
131.5
g/l
57.69
182
2029
193
2085
0.79
1.14
80.8
26.8
31.5
30.5
pg
5.44
184
2033
193
2085
0.79
1.14
81.2
26.9
3.2
4.3
e12/l
55.59
179
2003
193
2085
0.79
1.14
81.4
26.9
8.2
7.0
e9/l
0.40
180
2002
193
2084
0.79
1.13
81.1
26.8
96.0
92.0
fl
10.26
184
2033
193
2084
0.79
1.13
81.7
26.9
157.8
234.6
e9/l
12.21
178
2015
7
140
0.49
1.12
6.1
5.0
—
—
—
0
0
9
166
0.53
1.11
2.7
3.8
—
—
—
0
0
7
34
2.08
1.03
1.4
1.3
—
—
—
0
0
151
1353
1.24
1.03
8.9
4.5
7.2
6.9
mmol/l
0.80
142
1271
0
30
0.00
0.98
0.0
2.9
—
52.3
—
0
30
26
183
1.46
0.97
5.7
3.6
5.4
5.1
kpa
0.57
19
165
6
27
2.25
0.94
1.0
1.2
—
—
—
0
0
192
2055
0.82
0.91
49.9
22.0
4.0
4.0
mmol/l
0.43
183
1985
65
537
1.27
0.90
4.1
3.2
518.1
557.7
mosm/kgh2o
1.06
60
461
67
556
1.26
0.90
1.7
1.9
248000571.6
427.3
pmol/l
0.49
50
456
192
2053
0.82
0.89
47.4
21.9
138.6
139.5
mmol/l
4.33
181
1981
26
187
1.43
0.88
2.7
1.7
322.1
370.5
nmol/l
0.51
26
163
8
138
0.57
0.85
1.8
1.5
—
—
—
0
0
25
181
1.42
0.83
5.5
3.7
—
7.4
—
0
18
73
619
1.24
0.81
5.2
3.4
—
—
—
0
0
39
307
1.31
0.79
4.8
5.5
1.0
1.4
mmol/l
0.16
31
241
0
27
0.00
0.78
0.0
1.1
—
273.3
—
0
15
58
482
1.25
0.77
3.9
3.9
89.9
238.4
ng/l
1.09
49
431
176
1634
1.19
0.74
22.7
7.0
79.5
80.2
u/l
0.09
164
1512
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
5
28
1.80
0.66
3.4
4.3
—
—
—
0
0
30
235
1.31
0.64
2.3
2.7
2.3
7.0
ug/l
3.40
19
203
6
103
0.57
0.63
2.5
3.1
10.2
1848.7
u/ml
—
6
86
86
762
1.18
0.61
5.2
3.6
411.9
165.9
e6/l
0.32
72
607
93
1035
0.85
0.61
5.3
4.6
0.0
0.0
estimate
0.00
14
206
38
311
1.25
0.59
10.4
5.9
103.9
104.0
mmol/l
0.09
38
303
0
23
0.00
0.58
0.0
4.5
—
—
—
0
0
0
23
0.00
0.58
0.0
4.4
—
—
—
0
0
92
1018
0.86
0.55
7.2
6.1
0.0
0.0
estimate
0.00
17
211
62
539
1.19
0.55
3.8
2.8
6.9
4.6
e6/l
1.39
56
479
20
258
0.76
0.53
1.8
1.3
—
—
—
0
0
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
158
1486
1.13
0.48
5.4
4.3
26.0
15.4
mm/h
5.20
142
1335
7
46
1.53
0.48
1.6
2.3
—
—
—
0
0
7
46
1.53
0.48
1.7
1.2
—
—
—
0
0
93
1016
0.88
0.46
5.3
4.4
0.0
0.0
estimate
0.00
18
213
154
1451
1.13
0.45
6.7
4.9
—
—
—
0
0
94
862
1.13
0.42
40.4
10.5
0.6
0.0
e9/l
0.55
81
721
5
32
1.57
0.42
2.8
1.8
88.5
88.6
%
—
5
32
13
96
1.37
0.42
1.1
1.2
—
—
—
0
0
24
195
1.25
0.42
2.8
3.7
—
—
—
0
0
5
33
1.52
0.41
1.6
1.6
53.8
60.9
%
—
5
33
17
132
1.31
0.41
7.1
7.2
22.4
24.7
mmol/l
0.85
17
118
0
16
0.00
0.41
0.0
1.0
—
282.5
—
0
6
9
68
1.33
0.38
7.8
5.1
2.2
3.0
mmol/l
—
9
42
91
839
1.12
0.37
6.4
4.2
101.0
208.2
e6/l
0.60
74
641
20
244
0.81
0.36
1.2
1.3
1.0
19.6
u/ml
—
7
86
13
100
1.31
0.34
1.3
1.1
—
—
—
0
0
17
209
0.80
0.33
1.5
1.3
—
—
—
0
0
7
57
1.23
0.29
1.3
1.1
—
—
—
0
0
23
196
1.19
0.28
7.6
6.7
—
—
—
0
0
72
669
1.10
0.26
5.4
3.5
0.6
0.5
e6/l
0.10
58
522
84
791
1.09
0.23
5.6
3.7
—
—
—
0
0
0
11
0.00
0.21
0.0
5.1
—
24.6
—
0
11
0
10
0.00
0.21
0.0
1.4
—
29.6
—
0
10
0
12
0.00
0.21
0.0
5.2
—
—
—
0
0
0
12
0.00
0.21
0.0
5.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
133
1375
0.94
0.18
4.0
3.7
14.9
15.2
pmol/l
0.41
112
1185
43
464
0.91
0.18
5.6
5.0
1.0
1.0
kg/l
—
6
83
12
142
0.84
0.18
1.3
1.3
—
—
—
0
0
165
1606
1.06
0.17
57.0
20.1
29.6
37.4
%
13.76
83
930
5
69
0.72
0.17
24.6
11.5
—
—
—
0
0
8
70
1.15
0.16
4.6
3.9
—
—
—
0
0
6
76
0.79
0.16
1.0
1.1
—
88.8
—
0
20
12
102
1.18
0.15
5.6
4.3
—
—
—
0
0
16
140
1.15
0.15
3.8
2.6
—
—
—
0
0
191
1946
0.95
0.14
53.5
18.7
33.0
27.8
mg/l
0.97
177
1659
8
100
0.79
0.14
4.9
5.6
—
—
—
0
0
24
261
0.91
0.12
1.0
1.2
18.0
45.1
iu/ml
—
5
82
104
1012
1.04
0.10
4.6
4.5
30.0
44.3
ng/l
1.89
82
803
47
449
1.06
0.09
5.5
4.2
—
—
—
0
0
6
58
1.04
0.08
1.7
1.3
51.8
60.1
mmol/l
—
6
52
5
61
0.82
0.08
2.2
1.6
—
—
—
0
0
57
590
0.96
0.08
5.6
4.6
0.0
0.0
estimate
0.00
13
202
7
84
0.83
0.07
5.9
3.1
4.2
4.0
mmol/l
—
7
75
32
334
0.95
0.05
1.3
1.2
7.2
1.5
u/ml
—
8
85
71
726
0.97
0.05
4.9
4.5
—
—
—
0
0
11
120
0.91
0.05
2.3
3.1
—
—
—
0
0
78
766
1.02
0.04
3.4
3.1
2.3
2.3
mmol/l
2.03
63
658
11
102
1.08
0.03
1.5
1.2
—
—
—
0
0
18
187
0.96
0.01
5.9
3.8
—
—
—
0
0
69
698
0.99
0.01
1.8
2.1
95.8
383.7
u/l
1.97
62
653
26
261
1.00
0.00
2.2
4.2
3.8
40.1
ug/l
0.79
20
222
76
761
1.00
0.00
2.4
2.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
8
79
1.01
0.00
1.5
1.2
102.7
283.9
u/ml
—
8
69
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
3.2
—
0
8
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
5
57
0.88
0.00
2.8
2.3
—
15.6
—
0
28
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
6.1
—
0
7
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_MYELODYSP_SYNDR – Myelodysplastic syndrome

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).